BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37441734)

  • 1. A Case for Synthetic Data in Regulatory Decision-Making in Europe.
    Alloza C; Knox B; Raad H; Aguilà M; Coakley C; Mohrova Z; Boin É; Bénard M; Davies J; Jacquot E; Lecomte C; Fabre A; Batech M
    Clin Pharmacol Ther; 2023 Oct; 114(4):795-801. PubMed ID: 37441734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations to overcome barriers to the use of artificial intelligence-driven evidence in health technology assessment.
    Zemplényi A; Tachkov K; Balkanyi L; Németh B; Petykó ZI; Petrova G; Czech M; Dawoud D; Goettsch W; Gutierrez Ibarluzea I; Hren R; Knies S; Lorenzovici L; Maravic Z; Piniazhko O; Savova A; Manova M; Tesar T; Zerovnik S; Kaló Z
    Front Public Health; 2023; 11():1088121. PubMed ID: 37181704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidance on using real-world evidence from Western Europe in Central and Eastern European health policy decision making.
    Németh B; Kamusheva M; Mitkova Z; Petykó ZI; Zemplényi A; Dimitrova M; Tachkov K; Balkányi L; Czech M; Dawoud D; Goettsch W; Hren R; Knies S; Lorenzovici L; Maravic Z; Piniazhko O; Zerovnik S; Kaló Z
    J Comp Eff Res; 2023 Apr; 12(4):e220157. PubMed ID: 36861458
    [No Abstract]   [Full Text] [Related]  

  • 5. Health technology assessment of medical devices: What is different? An overview of three European projects.
    Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The challenges and opportunities in using real-world data to drive advances in healthcare in East Asia: expert panel recommendations.
    Crane G; Lim JCW; Gau CS; Xie J; Chu L
    Curr Med Res Opin; 2022 Sep; 38(9):1543-1551. PubMed ID: 35786170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strengthening the Interface of Evidence-Based Decision Making Across European Regulators and Health Technology Assessment Bodies.
    Jansen E; Hines PA; Berntgen M; Brand A
    Value Health; 2022 Oct; 25(10):1726-1735. PubMed ID: 35370077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can we use existing guidance to support the development of robust real-world evidence for health technology assessment/payer decision-making?
    Capkun G; Corry S; Dowling O; Asad Zadeh Vosta Kolaei F; Takyar S; Furtado C; Jónsson P; Kleinermans D; Lambert L; Schiel A; Facey K
    Int J Technol Assess Health Care; 2022 Nov; 38(1):e79. PubMed ID: 36321447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transferability of real-world data across borders for regulatory and health technology assessment decision-making.
    Jaksa A; Arena PJ; Chan KKW; Ben-Joseph RH; Jónsson P; Campbell UB
    Front Med (Lausanne); 2022; 9():1073678. PubMed ID: 36465931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do existing real-world data sources generate suitable evidence for the HTA of medical devices in Europe? Mapping and critical appraisal.
    Pongiglione B; Torbica A; Blommestein H; de Groot S; Ciani O; Walker S; Dams F; Blankart R; Mollenkamp M; Kovács S; Tarricone R; Drummond M
    Int J Technol Assess Health Care; 2021 Apr; 37(1):e62. PubMed ID: 33896433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Policy developments of health technology assessment in the European Union].
    Baran-Kooiker A; Czech M; Hołownia-Voloskova M
    Postepy Biochem; 2019 Nov; 65(4):319-321. PubMed ID: 31945287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Data Governance for Real-World Data Management: A Proposal for a Checklist to Support Decision Making.
    Solà-Morales O; Sigurðardóttir K; Akehurst R; Murphy LA; Mestre-Ferrandiz J; Cunningham D; de Pouvourville G
    Value Health; 2023 Apr; 26(4S):32-42. PubMed ID: 36870678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using real-world evidence in healthcare from Western to Central and Eastern Europe: a review of existing barriers.
    Kamusheva M; Németh B; Zemplényi A; Kaló Z; Elvidge J; Dimitrova M; Pontén J; Tachkov K; Mitkova Z
    J Comp Eff Res; 2022 Aug; 11(12):905-913. PubMed ID: 35726611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality Criteria for Real-world Data in Pharmaceutical Research and Health Care Decision-making: Austrian Expert Consensus.
    Klimek P; Baltic D; Brunner M; Degelsegger-Marquez A; Garhöfer G; Gouya-Lechner G; Herzog A; Jilma B; Kähler S; Mikl V; Mraz B; Ostermann H; Röhl C; Scharinger R; Stamm T; Strassnig M; Wirthumer-Hoche C; Pleiner-Duxneuner J
    JMIR Med Inform; 2022 Jun; 10(6):e34204. PubMed ID: 35713954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New and emerging technology for adult social care - the example of home sensors with artificial intelligence (AI) technology.
    Glasby J; Litchfield I; Parkinson S; Hocking L; Tanner D; Roe B; Bousfield J
    Health Soc Care Deliv Res; 2023 Jun; 11(9):1-64. PubMed ID: 37470136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Big data and predictive analytics in healthcare in Bangladesh: regulatory challenges.
    Hassan S; Dhali M; Zaman F; Tanveer M
    Heliyon; 2021 Jun; 7(6):e07179. PubMed ID: 34141936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA Agencies.
    Makady A; Ham RT; de Boer A; Hillege H; Klungel O; Goettsch W;
    Value Health; 2017 Apr; 20(4):520-532. PubMed ID: 28407993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolving Acceptance and Use of RWE for Regulatory Decision Making on the Benefit/Risk Assessment of a Drug in Japan.
    Nishioka K; Makimura T; Ishiguro A; Nonaka T; Yamaguchi M; Uyama Y
    Clin Pharmacol Ther; 2022 Jan; 111(1):35-43. PubMed ID: 34528701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Real-world Data for New Drug Applications and Line Extensions.
    Bolislis WR; Fay M; Kühler TC
    Clin Ther; 2020 May; 42(5):926-938. PubMed ID: 32340916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to Deal with the Inevitable: Generating Real-World Data and Using Real-World Evidence for HTA Purposes - From Theory to Action.
    Oortwijn W; Sampietro-Colom L; Trowman R
    Int J Technol Assess Health Care; 2019; 35(4):346-350. PubMed ID: 31198129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.